Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

SRx Health Solutions (SRXH) Long-Term Debt Repayments (2017 - 2025)

Historic Long-Term Debt Repayments for SRx Health Solutions (SRXH) over the last 7 years, with Q2 2025 value amounting to $7.6 million.

  • SRx Health Solutions' Long-Term Debt Repayments rose 44385.71% to $7.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $9.0 million, marking a year-over-year decrease of 3950.34%. This contributed to the annual value of $13.5 million for FY2023, which is 13936.17% up from last year.
  • According to the latest figures from Q2 2025, SRx Health Solutions' Long-Term Debt Repayments is $7.6 million, which was up 44385.71% from $1.4 million recorded in Q2 2024.
  • Over the past 5 years, SRx Health Solutions' Long-Term Debt Repayments peaked at $13.5 million during Q2 2023, and registered a low of -$2.8 million during Q4 2023.
  • Over the past 5 years, SRx Health Solutions' median Long-Term Debt Repayments value was $1.4 million (recorded in 2024), while the average stood at $2.8 million.
  • Examining YoY changes over the last 5 years, SRx Health Solutions' Long-Term Debt Repayments showed a top increase of 322666.67% in 2022 and a maximum decrease of 133333.33% in 2022.
  • SRx Health Solutions' Long-Term Debt Repayments (Quarter) stood at $150000.0 in 2021, then skyrocketed by 3226.67% to $5.0 million in 2022, then tumbled by 155.93% to -$2.8 million in 2023, then skyrocketed by 150.16% to $1.4 million in 2024, then soared by 443.86% to $7.6 million in 2025.
  • Its last three reported values are $7.6 million in Q2 2025, $1.4 million for Q2 2024, and -$2.8 million during Q4 2023.